Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
125,684,656
-
Total 13F shares
-
40,125,707
-
Share change
-
+8,013,599
-
Total reported value
-
$782,326,949
-
Put/Call ratio
-
100%
-
Price per share
-
$19.50
-
Number of holders
-
92
-
Value change
-
+$160,534,739
-
Number of buys
-
48
-
Number of sells
-
45
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q1 2019
As of 31 Mar 2019,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,125,707 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Cormorant Asset Management, LP, HILLHOUSE CAPITAL ADVISORS, LTD., HILLHOUSE CAPITAL MANAGEMENT, LTD., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, Sectoral Asset Management Inc, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.